PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes
Cancer Genomics - Proteomics · 2024
DOI: 10.21873/cgp.20470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2024. Verfasst von Ioannis A Voutsadakis. Beteiligte Einrichtung: Algoma District Cancer Program, Sault Area Hospital, Sault Ste Marie, ON, Canada; ivoutsadakis@nosm.ca. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Class I Phosphatidylinositol 3-Kinases, Mutation, Proto-Oncogene Proteins B-raf. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Algoma District Cancer Program, Sault Area Hospital, Sault Ste Marie, ON, Canada; ivoutsadakis@nosm.ca.
- Division of Clinical Sciences, Section of Internal Medicine, Northern Ontario School of Medicine, Sudbury, ON, Canada.
Zitieren
APA
Voutsadakis, I. A. (2024). PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20470
Vancouver
Voutsadakis IA. PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes. Cancer Genomics - Proteomics. 2024. doi:10.21873/cgp.20470
BibTeX
@article{Voutsadakis2024,
author = {Voutsadakis, Ioannis A},
title = {PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes},
journal = {Cancer Genomics - Proteomics},
year = {2024},
doi = {10.21873/cgp.20470}
}
EUVIMED